(Q41946145)

14 October 2017

title

Leflunomide/chloroquin combination therapy in rheumatoid arthritis: a pilot study (English)

1 reference

14 October 2017

1 reference

Bernhard Rintelen

1

1 reference

14 October 2017

Ingrid Andel

series ordinal

2

1 reference

14 October 2017

Judith Sautner

series ordinal

3

1 reference

14 October 2017

Burkhard F Leeb

series ordinal

4

1 reference

14 October 2017

publication date

4 January 2006

1 reference

14 October 2017

published in

Clinical Rheumatology

1 reference

14 October 2017

volume

25

1 reference

14 October 2017

issue

4

1 reference

14 October 2017

page(s)

557-559

1 reference

Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial

14 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-005-0149-2

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-005-0149-2

A proposed treatment algorithm for rheumatoid arthritis: aggressive therapy, methotrexate, and quantitative measures.

21 January 2018

1 reference

12 December 2020

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

1 reference

12 December 2020

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

12 December 2020

Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

12 December 2020

10.1007/S10067-005-0149-2

Identifiers

DOI

1 reference

14 October 2017

1 reference